CA
GILD icon

Claro Advisors’s Gilead Sciences GILD Stock Holding History

Claro Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$585K Buy
+4,194
New +$587K 0.07% 212
2025
Q3 		– Sell
-3,202
Closed -$355K – 409
2025
Q2 		$355K Sell
3,202
-7,685
-71% -$818K 0.06% 260
2025
Q1 		$1.22M Sell
10,887
-285
-3% -$29.4K 0.16% 119
2024
Q4 		$1.03M Buy
11,172
+2,617
+31% +$236K 0.14% 135
2024
Q3 		$717K Buy
8,555
+1,187
+16% +$90.6K 0.09% 207
2024
Q2 		$506K Buy
7,368
+374
+5% +$25K 0.08% 233
2024
Q1 		$512K Sell
6,994
-676
-9% -$52K 0.09% 234
2023
Q4 		$621K Sell
7,670
-559
-7% -$43.5K 0.13% 180
2023
Q3 		$617K Sell
8,229
-1,938
-19% -$149K 0.15% 158
2023
Q2 		$784K Buy
10,167
+2,201
+28% +$176K 0.19% 127
2023
Q1 		$661K Buy
7,966
+2,780
+54% +$230K 0.19% 127
2022
Q4 		$445K Sell
5,186
-839
-14% -$66.4K 0.15% 176
2022
Q3 		$372K Hold
6,025
– – 0.15% 162
2022
Q2 		$372K Buy
6,025
+671
+13% +$41.5K 0.15% 162
2022
Q1 		$389K Hold
5,354
– – 0.14% 164
2021
Q4 		$389K Buy
5,354
+17
+0.3% +$1.17K 0.14% 164
2021
Q3 		$373K Buy
5,337
+253
+5% +$17.8K 0.16% 160
2021
Q2 		$350K Sell
5,084
-15
-0.3% -$1K 0.16% 155
2021
Q1 		$330K Buy
5,099
+339
+7% +$21.9K 0.17% 153
2020
Q4 		$277K Sell
4,760
-4
-0.1% -$241 0.15% 160
2020
Q3 		$301K Sell
4,764
-548
-10% -$38K 0.19% 138
2020
Q2 		$409K Sell
5,312
-73
-1% -$5.59K 0.28% 106
2020
Q1 		$403K Sell
5,385
-474
-8% -$32.8K 0.38% 82
2019
Q4 		$381K Sell
5,859
-409
-7% -$26.6K 0.29% 96
2019
Q3 		$397K Buy
6,268
+216
+4% +$14.1K 0.35% 84
2019
Q2 		$409K Sell
6,052
-273
-4% -$18K 0.38% 80
2019
Q1 		$411K Sell
6,325
-383
-6% -$25.5K 0.41% 75
2018
Q4 		$518K Buy
+6,708
New +$469K 0.41% 54

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Claro Advisors's GILD Position: Q1 2026 in Review

Claro Advisors opened a new position in Gilead Sciences (GILD) in Q1 2026: 4,194 shares worth $585K. The stake represents 0.07% of the portfolio and ranks #212 among its holdings. This is a return to the name: Claro Advisors previously reported a position in GILD as recently as Q2 2025.

Claro Advisors first reported a position in GILD in Q4 2018 and has held it in 28 quarters since. The position peaked at $1.22M in Q1 2025. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Claro Advisors held 4,194 shares of Gilead Sciences worth $585K as of Q1 2026.
  • Gilead Sciences was a new Claro Advisors position in Q1 2026.
  • Gilead Sciences made up 0.07% of Claro Advisors's portfolio in Q1 2026, its #212 holding.
  • Claro Advisors first reported a position in Gilead Sciences in Q4 2018 and has held it in 28 quarters since.
  • Claro Advisors's Gilead Sciences position peaked at $1.22M in Q1 2025.
  • 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Claro Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.